{"disease":{"id":"spider-veins","name":"spider veins"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07073742","title":"CLaCS Using 0.2% Aetoxysklerol Foam and 70% Glucose for the Treatment of Lower Limb Telangiectasias","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":240,"lead_sponsor_name":"Charles University, Czech Republic","has_results":false},{"nct_id":"NCT02754479","title":"A Clinical Evaluation of the Treatment of Spider Veins on the Ankles","phase":"NA","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Cutera Inc.","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}